Are pharma firms set for increased scrutiny?

How pharmaceutical firms price their products is getting a lot of additional attention in the United Kingdom and United States. Neil Hodge reports.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.